Hiroki Kaneko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroki Kaneko has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Hironobu Umakoshi
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
5 shared publications Yuki Ishihara
Department of Endocrinology and Metabolism National Hospital Organization Kyoto Medical Center Kyoto Japan
3 shared publicationsAkihiro Yasoda
Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publicationsKazutaka Nanba
Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publicationsMika Tsuiki
Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publicationsShohei Sakamoto
Department of Metabolism and Endocrinology, NHO Kyushu Medical Center, Fukuoka, Japan (S.S., T.W.).
2 shared publications
Latest Publications
- 1 May 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (5)
Role of Stress-Responsive NR4A2 in Aldosterone-Producing Cell Cluster Formation
BACKGROUND: Aldosterone-producing cell clusters (APCCs), which share some transcriptomic features with aldosterone-producing adenomas, are frequently observed in the adrenal cortex of aged individuals and those with primary aldosteronism. However, the mechanisms driving APCC formation remain poorly understood. METHODS: We performed an integrated analysis using spatial transcriptomics and single-cell RNA sequencing of APCC cells, aldosterone-producing adenoma cells, and zona glomerulosa (ZG) cells present in the same adrenal gland of a patient with unilateral primary aldosteronism, with validation analyses conducted on tissue samples from 2 additional patients. RESULTS: APCC cells exhibited a distinct cellular population with a gene expression profile more similar to that of the ZG cells than that of aldosterone-producing adenoma cells. In silico perturbation and in vitro studies suggest that the stress-responsive transcription factor NR4A2 (Nuclear receptor subfamily 4 group A member 2) is activated in ZG cells in response to a variety of stresses, such as adrenocorticotropic hormone stimulation, thereby promoting the progression from ZG to APCC cells. CONCLUSIONS: Our findings suggest that NR4A2 activation in ZG cells functions as a key molecular mediator in stress-induced APCC formation at least in some cases. Some APCCs maintained ZG-like characteristics with heightened stress responsiveness, representing a distinct cellular state from aldosterone-producing adenomas, which exhibit metabolic reprogramming and enhanced energy metabolism.
- 1 May 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (5)
Role of Stress-Responsive NR4A2 in Aldosterone-Producing Cell Cluster Formation
BACKGROUND: Aldosterone-producing cell clusters (APCCs), which share some transcriptomic features with aldosterone-producing adenomas, are frequently observed in the adrenal cortex of aged individuals and those with primary aldosteronism. However, the mechanisms driving APCC formation remain poorly understood. METHODS: We performed an integrated analysis using spatial transcriptomics and single-cell RNA sequencing of APCC cells, aldosterone-producing adenoma cells, and zona glomerulosa (ZG) cells present in the same adrenal gland of a patient with unilateral primary aldosteronism, with validation analyses conducted on tissue samples from 2 additional patients. RESULTS: APCC cells exhibited a distinct cellular population with a gene expression profile more similar to that of the ZG cells than that of aldosterone-producing adenoma cells. In silico perturbation and in vitro studies suggest that the stress-responsive transcription factor NR4A2 (Nuclear receptor subfamily 4 group A member 2) is activated in ZG cells in response to a variety of stresses, such as adrenocorticotropic hormone stimulation, thereby promoting the progression from ZG to APCC cells. CONCLUSIONS: Our findings suggest that NR4A2 activation in ZG cells functions as a key molecular mediator in stress-induced APCC formation at least in some cases. Some APCCs maintained ZG-like characteristics with heightened stress responsiveness, representing a distinct cellular state from aldosterone-producing adenomas, which exhibit metabolic reprogramming and enhanced energy metabolism.
- Open Access
- 20 December 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (1) , 100492
Wide-scope targeted analysis of bioactive lipids in human plasma by LC/MS/MS
- 20 December 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (1) , 100492
Open AccessWide-scope targeted analysis of bioactive lipids in human plasma by LC/MS/MS
- 1 December 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 98 (4) , 473-480
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Objective: The clinical practice guideline for primary aldosteronism (PA) places a high value on confirmatory tests to sparing patients with false‐positive results in case detection from undergoing adrenal venous sampling (AVS). However, it is unclear whether multiple types of confirmatory tests are more useful than a single type. To evaluate whether the machine‐learned combination of two confirmatory tests is more useful in predicting subtypes of PA than each test alone.Design: A retrospective cross‐sectional study in referral centres.Patients: This study included 615 patients with PA randomly assigned to the training and test data sets. The participants underwent saline infusion test (SIT) and captopril challenge test (CCT) and were subtyped by AVS (unilateral, n = 99; bilateral, n = 516).Measurements: The area under the curve (AUC) and clinical usefulness using decision curve analysis for the subtype prediction in the test data set.Results: The AUCs for the combination of SIT and CCT, SIT alone and CCT alone were 0.850, 0.813 and 0.786, respectively, with no significant differences between them. The AUC for the baseline clinical characteristics alone was 0.872, whereas the AUCs for these combined with SIT, combined with CCT and combined with both SIT and CCT were 0.868, 0.854 and 0.855, respectively, with no significant improvement in AUC. The additional clinical usefulness of the second confirmatory test was unremarkable on decision curve analysis.Conclusions: Our data suggest that patients with positive case detection undergo one confirmatory test to determine the indication for AVS.
- 1 December 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 98 (4) , 473-480
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Objective: The clinical practice guideline for primary aldosteronism (PA) places a high value on confirmatory tests to sparing patients with false‐positive results in case detection from undergoing adrenal venous sampling (AVS). However, it is unclear whether multiple types of confirmatory tests are more useful than a single type. To evaluate whether the machine‐learned combination of two confirmatory tests is more useful in predicting subtypes of PA than each test alone.Design: A retrospective cross‐sectional study in referral centres.Patients: This study included 615 patients with PA randomly assigned to the training and test data sets. The participants underwent saline infusion test (SIT) and captopril challenge test (CCT) and were subtyped by AVS (unilateral, n = 99; bilateral, n = 516).Measurements: The area under the curve (AUC) and clinical usefulness using decision curve analysis for the subtype prediction in the test data set.Results: The AUCs for the combination of SIT and CCT, SIT alone and CCT alone were 0.850, 0.813 and 0.786, respectively, with no significant differences between them. The AUC for the baseline clinical characteristics alone was 0.872, whereas the AUCs for these combined with SIT, combined with CCT and combined with both SIT and CCT were 0.868, 0.854 and 0.855, respectively, with no significant improvement in AUC. The additional clinical usefulness of the second confirmatory test was unremarkable on decision curve analysis.Conclusions: Our data suggest that patients with positive case detection undergo one confirmatory test to determine the indication for AVS.
- Open Access
- 22 July 2020
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 4 (9) , bvaa100
Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism
Context Urinary aldosterone levels (Uald) are widely measured in the oral sodium-loading test to confirm primary aldosteronism (PA), but reliable studies on their diagnostic value are limited. This may be due to the difficulty in collecting urine with reliable accuracy, keeping oral sodium intake constant between patients. Therefore, we focused on 24-hour Uald after intravenous saline infusion in a hospitalized setting, which provides a reliable sodium load in consistent amounts. Objective Comparing plasma aldosterone concentrations (PAC) and Uald after saline infusion in the sitting position, to evaluate the accuracy in determining PA subtypes and the correlation of both measurements. Design and Setting This was a retrospective cross-sectional study in a single referral center. Patients Of 53 patients without renal dysfunction who were diagnosed with PA and underwent adrenal venous sampling, 16 and 37 were diagnosed with unilateral and bilateral PA, respectively. Main Outcome Measures Uald collected for 24 hours and PAC after saline infusion. Results The area under the receiver operating characteristic curve for diagnosing unilateral PA was not significantly different between Uald and PAC after saline infusion (0.921 and 0.958, respectively; P = 0.370). The predicted optimal cutoff value of Uald was 16.5 μg/day (sensitivity, 87.5%; specificity, 100%), and that of PAC after saline infusion was 19.3 ng/dL (sensitivity, 87.5%; specificity, 97.3%). In studied patients with PA, Uald was positively correlated with PAC after saline infusion (r = 0.617; P < 0.001). Conclusions We reassessed Uald in PA patients under sufficient sodium loading and demonstrated the correlation between Uald and PAC after saline infusion.
- 22 July 2020
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 4 (9) , bvaa100
Open AccessReassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism
Context Urinary aldosterone levels (Uald) are widely measured in the oral sodium-loading test to confirm primary aldosteronism (PA), but reliable studies on their diagnostic value are limited. This may be due to the difficulty in collecting urine with reliable accuracy, keeping oral sodium intake constant between patients. Therefore, we focused on 24-hour Uald after intravenous saline infusion in a hospitalized setting, which provides a reliable sodium load in consistent amounts. Objective Comparing plasma aldosterone concentrations (PAC) and Uald after saline infusion in the sitting position, to evaluate the accuracy in determining PA subtypes and the correlation of both measurements. Design and Setting This was a retrospective cross-sectional study in a single referral center. Patients Of 53 patients without renal dysfunction who were diagnosed with PA and underwent adrenal venous sampling, 16 and 37 were diagnosed with unilateral and bilateral PA, respectively. Main Outcome Measures Uald collected for 24 hours and PAC after saline infusion. Results The area under the receiver operating characteristic curve for diagnosing unilateral PA was not significantly different between Uald and PAC after saline infusion (0.921 and 0.958, respectively; P = 0.370). The predicted optimal cutoff value of Uald was 16.5 μg/day (sensitivity, 87.5%; specificity, 100%), and that of PAC after saline infusion was 19.3 ng/dL (sensitivity, 87.5%; specificity, 97.3%). In studied patients with PA, Uald was positively correlated with PAC after saline infusion (r = 0.617; P < 0.001). Conclusions We reassessed Uald in PA patients under sufficient sodium loading and demonstrated the correlation between Uald and PAC after saline infusion.
- 16 October 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (6) , 737-742
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism
Context: Although saline infusion test is widely used as a confirmatory test for primary aldosteronism (PA), it is reportedly less sensitive in patients in whom aldosterone is responsive to the upright position by performing it in recumbent position. Based on a single‐centre experience, seated saline infusion test (SSIT) has been reported to be highly sensitive and superior to recumbent testing in identifying both unilateral and bilateral forms of PA. However, due to limited participants number, the utility of SSIT needs to be validated in other series.Objective: This study aimed to evaluate the accuracy of SSIT in determining the PA subtypes compared with adrenocorticotropic hormone stimulation test under dexamethasone suppression (Dex‐AT).Patients and Setting: Sixty‐four patients with PA who underwent both SSIT and Dex‐AT were included. Subtype diagnosis of PA was determined by adrenal venous sampling (AVS) (16 unilateral and 48 bilateral forms).Main Outcome Measure: Plasma aldosterone concentrations (PACs) were measured after SSIT and Dex‐AT.Results: The area under the receiver operating characteristic (ROC) curve for diagnosing unilateral PA was greater in SSIT than that in Dex‐AT (0.907 vs. 0.755; P = .023). ROC curve analysis predicted optimal cut‐off PACs of 13.1 ng/dL (sensitivity, 93.8%; specificity, 79.2%) for SSIT and 34.2 ng/dL (sensitivity, 75.0%; specificity, 68.8%) for Dex‐AT.Conclusions: Seated saline infusion test has superior accuracy in subtype diagnosis of PA compared with Dex‐AT. SSIT can be a sensitive test for determining patients who require AVS prior to surgery.
- 16 October 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (6) , 737-742
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism
Context: Although saline infusion test is widely used as a confirmatory test for primary aldosteronism (PA), it is reportedly less sensitive in patients in whom aldosterone is responsive to the upright position by performing it in recumbent position. Based on a single‐centre experience, seated saline infusion test (SSIT) has been reported to be highly sensitive and superior to recumbent testing in identifying both unilateral and bilateral forms of PA. However, due to limited participants number, the utility of SSIT needs to be validated in other series.Objective: This study aimed to evaluate the accuracy of SSIT in determining the PA subtypes compared with adrenocorticotropic hormone stimulation test under dexamethasone suppression (Dex‐AT).Patients and Setting: Sixty‐four patients with PA who underwent both SSIT and Dex‐AT were included. Subtype diagnosis of PA was determined by adrenal venous sampling (AVS) (16 unilateral and 48 bilateral forms).Main Outcome Measure: Plasma aldosterone concentrations (PACs) were measured after SSIT and Dex‐AT.Results: The area under the receiver operating characteristic (ROC) curve for diagnosing unilateral PA was greater in SSIT than that in Dex‐AT (0.907 vs. 0.755; P = .023). ROC curve analysis predicted optimal cut‐off PACs of 13.1 ng/dL (sensitivity, 93.8%; specificity, 79.2%) for SSIT and 34.2 ng/dL (sensitivity, 75.0%; specificity, 68.8%) for Dex‐AT.Conclusions: Seated saline infusion test has superior accuracy in subtype diagnosis of PA compared with Dex‐AT. SSIT can be a sensitive test for determining patients who require AVS prior to surgery.